APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Morquio Syndrome Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Morquio Syndrome Treatment Market Analysis and Forecast 2026-2032

Report ID 174014380219 December 2025201 pages

Choose your research edition.

Industry ResearchMorquio Syndrome Treatment Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Morquio Syndrome Treatment Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Morquio Syndrome Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Morquio Syndrome Treatment Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Morquio Syndrome Treatment Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Morquio Syndrome Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Morquio Syndrome Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Morquio Syndrome Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Morquio Syndrome Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Morquio Syndrome Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Morquio Syndrome Treatment include Sanofi, Roche, Pfizer, Bayer, Shire, Sangamo Therapeutics, Lupin, JCR Pharmaceuticals and Green Cross, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Morquio Syndrome Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Morquio Syndrome Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Morquio Syndrome Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Morquio Syndrome Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Morquio Syndrome Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Morquio Syndrome Treatment revenue, projected growth trends, production technology, application and end-user industry.

Morquio Syndrome Treatment Segment by Company

Sanofi

Roche

Pfizer

Bayer

Shire

Sangamo Therapeutics

Lupin

JCR Pharmaceuticals

Green Cross

Genzyme Corporation,

Daiichi Sankyo

Concert Pharmaceuticals

Cipla

Cambrex Corporation

BioMarin

Alexion Pharmaceuticals

Morquio Syndrome Treatment Segment by Type

Morquio A

Morquio B

Morquio Syndrome Treatment Segment by Application

Hospital

Clinic

Others

Morquio Syndrome Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Morquio Syndrome Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Morquio Syndrome Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Morquio Syndrome Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Morquio Syndrome Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Morquio Syndrome Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Morquio Syndrome Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Morquio Syndrome Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Morquio A Major Player Table 3. Morquio B Major Player Table 4. Global Morquio Syndrome Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Others Major Player Table 8. Morquio Syndrome Treatment Industry Trends Table 9. Morquio Syndrome Treatment Industry Drivers Table 10. Morquio Syndrome Treatment Industry Opportunities and Challenges Table 11. Morquio Syndrome Treatment Industry Restraints Table 12. Global Morquio Syndrome Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Morquio Syndrome Treatment Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Morquio Syndrome Treatment Market Share by Region (2021-2026) Table 15. Global Morquio Syndrome Treatment Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Morquio Syndrome Treatment Market Share by Region (2027-2032) Table 17. Global Morquio Syndrome Treatment Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Morquio Syndrome Treatment Revenue Market Share by Players (2021-2026) Table 19. Global Morquio Syndrome Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Morquio Syndrome Treatment Key Players Headquarters & Area Served Table 21. Global Morquio Syndrome Treatment Players, Product Type & Application Table 22. Global Morquio Syndrome Treatment Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Morquio Syndrome Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Morquio Syndrome Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Morquio Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Morquio Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Morquio Syndrome Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Morquio Syndrome Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Morquio Syndrome Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Morquio Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Morquio Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Morquio Syndrome Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Morquio Syndrome Treatment Revenue Market Share by Application (2027-2032) Table 35. Sanofi Company Information Table 36. Sanofi Business Overview Table 37. Sanofi Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Sanofi Morquio Syndrome Treatment Product Portfolio Table 39. Sanofi Recent Development Table 40. Roche Company Information Table 41. Roche Business Overview Table 42. Roche Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Roche Morquio Syndrome Treatment Product Portfolio Table 44. Roche Recent Development Table 45. Pfizer Company Information Table 46. Pfizer Business Overview Table 47. Pfizer Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Pfizer Morquio Syndrome Treatment Product Portfolio Table 49. Pfizer Recent Development Table 50. Bayer Company Information Table 51. Bayer Business Overview Table 52. Bayer Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Bayer Morquio Syndrome Treatment Product Portfolio Table 54. Bayer Recent Development Table 55. Shire Company Information Table 56. Shire Business Overview Table 57. Shire Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Shire Morquio Syndrome Treatment Product Portfolio Table 59. Shire Recent Development Table 60. Sangamo Therapeutics Company Information Table 61. Sangamo Therapeutics Business Overview Table 62. Sangamo Therapeutics Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Sangamo Therapeutics Morquio Syndrome Treatment Product Portfolio Table 64. Sangamo Therapeutics Recent Development Table 65. Lupin Company Information Table 66. Lupin Business Overview Table 67. Lupin Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Lupin Morquio Syndrome Treatment Product Portfolio Table 69. Lupin Recent Development Table 70. JCR Pharmaceuticals Company Information Table 71. JCR Pharmaceuticals Business Overview Table 72. JCR Pharmaceuticals Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. JCR Pharmaceuticals Morquio Syndrome Treatment Product Portfolio Table 74. JCR Pharmaceuticals Recent Development Table 75. Green Cross Company Information Table 76. Green Cross Business Overview Table 77. Green Cross Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Green Cross Morquio Syndrome Treatment Product Portfolio Table 79. Green Cross Recent Development Table 80. Genzyme Corporation, Company Information Table 81. Genzyme Corporation, Business Overview Table 82. Genzyme Corporation, Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Genzyme Corporation, Morquio Syndrome Treatment Product Portfolio Table 84. Genzyme Corporation, Recent Development Table 85. Daiichi Sankyo Company Information Table 86. Daiichi Sankyo Business Overview Table 87. Daiichi Sankyo Morquio Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Daiichi Sankyo Morquio Syndrome Treatment Product Portfolio Table 89. Daiichi Sankyo Recent Development Table 90. Concert Pharmaceuticals Company Information Table 91. Concert Pharmaceuticals Business Overview Table 92. Concert Pharmaceuticals Morquio Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Concert Pharmaceuticals Morquio Syndrome Treatment Product Portfolio Table 94. Concert Pharmaceuticals Recent Development Table 95. Cipla Company Information Table 96. Cipla Business Overview Table 97. Cipla Morquio Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Cipla Morquio Syndrome Treatment Product Portfolio Table 99. Cipla Recent Development Table 100. Cambrex Corporation Company Information Table 101. Cambrex Corporation Business Overview Table 102. Cambrex Corporation Morquio Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Cambrex Corporation Morquio Syndrome Treatment Product Portfolio Table 104. Cambrex Corporation Recent Development Table 105. BioMarin Company Information Table 106. BioMarin Business Overview Table 107. BioMarin Morquio Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. BioMarin Morquio Syndrome Treatment Product Portfolio Table 109. BioMarin Recent Development Table 110. Alexion Pharmaceuticals Company Information Table 111. Alexion Pharmaceuticals Business Overview Table 112. Alexion Pharmaceuticals Morquio Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Alexion Pharmaceuticals Morquio Syndrome Treatment Product Portfolio Table 114. Alexion Pharmaceuticals Recent Development Table 115. North America Morquio Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 116. North America Morquio Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 117. North America Morquio Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 118. North America Morquio Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 119. North America Morquio Syndrome Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Morquio Syndrome Treatment Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Morquio Syndrome Treatment Revenue by Country (US$ Million) & (2027-2032) Table 122. Europe Morquio Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 123. Europe Morquio Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 124. Europe Morquio Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 125. Europe Morquio Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 126. Europe Morquio Syndrome Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Morquio Syndrome Treatment Revenue by Country (2021-2026) & (US$ Million) Table 128. Europe Morquio Syndrome Treatment Revenue by Country (US$ Million) & (2027-2032) Table 129. China Morquio Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 130. China Morquio Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 131. China Morquio Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 132. China Morquio Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Morquio Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 134. Asia Morquio Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 135. Asia Morquio Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 136. Asia Morquio Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 137. Asia Morquio Syndrome Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Asia Morquio Syndrome Treatment Revenue by Region (US$ Million) & (2021-2026) Table 139. Asia Morquio Syndrome Treatment Revenue by Region (US$ Million) & (2027-2032) Table 140. SAMEA Morquio Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 141. SAMEA Morquio Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 142. SAMEA Morquio Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 143. SAMEA Morquio Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 144. SAMEA Morquio Syndrome Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. SAMEA Morquio Syndrome Treatment Revenue by Country (2021-2026) & (US$ Million) Table 146. SAMEA Morquio Syndrome Treatment Revenue by Country (US$ Million) & (2027-2032) Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Morquio Syndrome Treatment Image Figure 2. Global Morquio Syndrome Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Morquio Syndrome Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Morquio A Image Figure 5. Morquio B Image Figure 6. Global Morquio Syndrome Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Morquio Syndrome Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Morquio Syndrome Treatment Market Size (US$ Million) & (2021-2032) Figure 12. Global Morquio Syndrome Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Morquio Syndrome Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Morquio Syndrome Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Morquio Syndrome Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Morquio Syndrome Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Morquio Syndrome Treatment Revenue Market Share by Type (2021-2032) Figure 19. Global Morquio Syndrome Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Morquio Syndrome Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Morquio Syndrome Treatment Revenue Market Share by Application (2021-2032) Figure 22. North America Morquio Syndrome Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Morquio Syndrome Treatment Revenue Share by Type (2021-2032) Figure 24. North America Morquio Syndrome Treatment Revenue Share by Application (2021-2032) Figure 25. North America Morquio Syndrome Treatment Revenue Share by Country (2021-2032) Figure 26. United States Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Morquio Syndrome Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Morquio Syndrome Treatment Revenue Share by Type (2021-2032) Figure 31. Europe Morquio Syndrome Treatment Revenue Share by Application (2021-2032) Figure 32. Europe Morquio Syndrome Treatment Revenue Share by Country (2021-2032) Figure 33. Germany Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Morquio Syndrome Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Morquio Syndrome Treatment Revenue Share by Type (2021-2032) Figure 43. China Morquio Syndrome Treatment Revenue Share by Application (2021-2032) Figure 44. Asia Morquio Syndrome Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Morquio Syndrome Treatment Revenue Share by Type (2021-2032) Figure 46. Asia Morquio Syndrome Treatment Revenue Share by Application (2021-2032) Figure 47. Asia Morquio Syndrome Treatment Revenue Share by Region (2021-2032) Figure 48. Japan Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Morquio Syndrome Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Morquio Syndrome Treatment Revenue Share by Type (2021-2032) Figure 56. SAMEA Morquio Syndrome Treatment Revenue Share by Application (2021-2032) Figure 57. SAMEA Morquio Syndrome Treatment Revenue Share by Country (2021-2032) Figure 58. Brazil Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Morquio Syndrome Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Morquio A
  • Morquio B
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sanofi
  • Roche
  • Pfizer
  • Bayer
  • Shire
  • Sangamo Therapeutics
  • Lupin
  • JCR Pharmaceuticals
  • Green Cross
  • Genzyme Corporation,
  • Daiichi Sankyo
  • Concert Pharmaceuticals
  • Cipla
  • Cambrex Corporation
  • BioMarin
  • Alexion Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Morquio Syndrome Treatment Market by Type
  3. 1.2.1 Global Morquio Syndrome Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Morquio A
  5. 1.2.3 Morquio B
  6. 1.3 Morquio Syndrome Treatment Market by Application
  7. 1.3.1 Global Morquio Syndrome Treatment Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Morquio Syndrome Treatment Market Dynamics
  1. 2.1 Morquio Syndrome Treatment Industry Trends
  2. 2.2 Morquio Syndrome Treatment Industry Drivers
  3. 2.3 Morquio Syndrome Treatment Industry Opportunities and Challenges
  4. 2.4 Morquio Syndrome Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Morquio Syndrome Treatment Market Perspective (2021-2032)
  2. 3.2 Global Morquio Syndrome Treatment Growth Trends by Region
  3. 3.2.1 Global Morquio Syndrome Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Morquio Syndrome Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Morquio Syndrome Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Morquio Syndrome Treatment Revenue by Players
  2. 4.1.1 Global Morquio Syndrome Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Morquio Syndrome Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Morquio Syndrome Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Morquio Syndrome Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Morquio Syndrome Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Morquio Syndrome Treatment Players, Product Type & Application
  8. 4.5 Global Morquio Syndrome Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Morquio Syndrome Treatment Market CR5 and HHI
  11. 4.6.3 2025 Morquio Syndrome Treatment Tier 1, Tier 2, and Tier 3
5 Morquio Syndrome Treatment Market Size by Type
  1. 5.1 Global Morquio Syndrome Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Morquio Syndrome Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Morquio Syndrome Treatment Revenue Market Share by Type (2021-2032)
6 Morquio Syndrome Treatment Market Size by Application
  1. 6.1 Global Morquio Syndrome Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Morquio Syndrome Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Morquio Syndrome Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Morquio Syndrome Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Morquio Syndrome Treatment Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Roche
  8. 7.2.1 Roche Company Information
  9. 7.2.2 Roche Business Overview
  10. 7.2.3 Roche Morquio Syndrome Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Roche Morquio Syndrome Treatment Product Portfolio
  12. 7.2.5 Roche Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Morquio Syndrome Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Morquio Syndrome Treatment Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 Bayer
  20. 7.4.1 Bayer Company Information
  21. 7.4.2 Bayer Business Overview
  22. 7.4.3 Bayer Morquio Syndrome Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bayer Morquio Syndrome Treatment Product Portfolio
  24. 7.4.5 Bayer Recent Developments
  25. 7.5 Shire
  26. 7.5.1 Shire Company Information
  27. 7.5.2 Shire Business Overview
  28. 7.5.3 Shire Morquio Syndrome Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Shire Morquio Syndrome Treatment Product Portfolio
  30. 7.5.5 Shire Recent Developments
  31. 7.6 Sangamo Therapeutics
  32. 7.6.1 Sangamo Therapeutics Company Information
  33. 7.6.2 Sangamo Therapeutics Business Overview
  34. 7.6.3 Sangamo Therapeutics Morquio Syndrome Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sangamo Therapeutics Morquio Syndrome Treatment Product Portfolio
  36. 7.6.5 Sangamo Therapeutics Recent Developments
  37. 7.7 Lupin
  38. 7.7.1 Lupin Company Information
  39. 7.7.2 Lupin Business Overview
  40. 7.7.3 Lupin Morquio Syndrome Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Lupin Morquio Syndrome Treatment Product Portfolio
  42. 7.7.5 Lupin Recent Developments
  43. 7.8 JCR Pharmaceuticals
  44. 7.8.1 JCR Pharmaceuticals Company Information
  45. 7.8.2 JCR Pharmaceuticals Business Overview
  46. 7.8.3 JCR Pharmaceuticals Morquio Syndrome Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 JCR Pharmaceuticals Morquio Syndrome Treatment Product Portfolio
  48. 7.8.5 JCR Pharmaceuticals Recent Developments
  49. 7.9 Green Cross
  50. 7.9.1 Green Cross Company Information
  51. 7.9.2 Green Cross Business Overview
  52. 7.9.3 Green Cross Morquio Syndrome Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Green Cross Morquio Syndrome Treatment Product Portfolio
  54. 7.9.5 Green Cross Recent Developments
  55. 7.10 Genzyme Corporation,
  56. 7.10.1 Genzyme Corporation, Company Information
  57. 7.10.2 Genzyme Corporation, Business Overview
  58. 7.10.3 Genzyme Corporation, Morquio Syndrome Treatment Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Genzyme Corporation, Morquio Syndrome Treatment Product Portfolio
  60. 7.10.5 Genzyme Corporation, Recent Developments
  61. 7.11 Daiichi Sankyo
  62. 7.11.1 Daiichi Sankyo Company Information
  63. 7.11.2 Daiichi Sankyo Business Overview
  64. 7.11.3 Daiichi Sankyo Morquio Syndrome Treatment Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Daiichi Sankyo Morquio Syndrome Treatment Product Portfolio
  66. 7.11.5 Daiichi Sankyo Recent Developments
  67. 7.12 Concert Pharmaceuticals
  68. 7.12.1 Concert Pharmaceuticals Company Information
  69. 7.12.2 Concert Pharmaceuticals Business Overview
  70. 7.12.3 Concert Pharmaceuticals Morquio Syndrome Treatment Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Concert Pharmaceuticals Morquio Syndrome Treatment Product Portfolio
  72. 7.12.5 Concert Pharmaceuticals Recent Developments
  73. 7.13 Cipla
  74. 7.13.1 Cipla Company Information
  75. 7.13.2 Cipla Business Overview
  76. 7.13.3 Cipla Morquio Syndrome Treatment Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Cipla Morquio Syndrome Treatment Product Portfolio
  78. 7.13.5 Cipla Recent Developments
  79. 7.14 Cambrex Corporation
  80. 7.14.1 Cambrex Corporation Company Information
  81. 7.14.2 Cambrex Corporation Business Overview
  82. 7.14.3 Cambrex Corporation Morquio Syndrome Treatment Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Cambrex Corporation Morquio Syndrome Treatment Product Portfolio
  84. 7.14.5 Cambrex Corporation Recent Developments
  85. 7.15 BioMarin
  86. 7.15.1 BioMarin Company Information
  87. 7.15.2 BioMarin Business Overview
  88. 7.15.3 BioMarin Morquio Syndrome Treatment Revenue and Gross Margin (2021-2026)
  89. 7.15.4 BioMarin Morquio Syndrome Treatment Product Portfolio
  90. 7.15.5 BioMarin Recent Developments
  91. 7.16 Alexion Pharmaceuticals
  92. 7.16.1 Alexion Pharmaceuticals Company Information
  93. 7.16.2 Alexion Pharmaceuticals Business Overview
  94. 7.16.3 Alexion Pharmaceuticals Morquio Syndrome Treatment Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Alexion Pharmaceuticals Morquio Syndrome Treatment Product Portfolio
  96. 7.16.5 Alexion Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Morquio Syndrome Treatment Revenue (2021-2032)
  2. 8.2 North America Morquio Syndrome Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Morquio Syndrome Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Morquio Syndrome Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Morquio Syndrome Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Morquio Syndrome Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Morquio Syndrome Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Morquio Syndrome Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Morquio Syndrome Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Morquio Syndrome Treatment Revenue by Country
  11. 8.6.1 North America Morquio Syndrome Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Morquio Syndrome Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Morquio Syndrome Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Morquio Syndrome Treatment Revenue (2021-2032)
  2. 9.2 Europe Morquio Syndrome Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Morquio Syndrome Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Morquio Syndrome Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Morquio Syndrome Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Morquio Syndrome Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Morquio Syndrome Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Morquio Syndrome Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Morquio Syndrome Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Morquio Syndrome Treatment Revenue by Country
  11. 9.6.1 Europe Morquio Syndrome Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Morquio Syndrome Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Morquio Syndrome Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Morquio Syndrome Treatment Revenue (2021-2032)
  2. 10.2 China Morquio Syndrome Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Morquio Syndrome Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Morquio Syndrome Treatment Revenue by Type (2027-2032)
  5. 10.3 China Morquio Syndrome Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Morquio Syndrome Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Morquio Syndrome Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Morquio Syndrome Treatment Revenue by Application (2027-2032)
  9. 10.5 China Morquio Syndrome Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Morquio Syndrome Treatment Revenue (2021-2032)
  2. 11.2 Asia Morquio Syndrome Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Morquio Syndrome Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Morquio Syndrome Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Morquio Syndrome Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Morquio Syndrome Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Morquio Syndrome Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Morquio Syndrome Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Morquio Syndrome Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Morquio Syndrome Treatment Revenue by Country
  11. 11.6.1 Asia Morquio Syndrome Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Morquio Syndrome Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Morquio Syndrome Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Morquio Syndrome Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Morquio Syndrome Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Morquio Syndrome Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Morquio Syndrome Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Morquio Syndrome Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Morquio Syndrome Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Morquio Syndrome Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Morquio Syndrome Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Morquio Syndrome Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Morquio Syndrome Treatment Revenue by Country
  11. 12.6.1 SAMEA Morquio Syndrome Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Morquio Syndrome Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Morquio Syndrome Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst